Hematology

Filter

New Study Links Systemic Sclerosis to Higher Cancer Risk

October 2025

Study links systemic sclerosis to elevated cancer risks, varying by specific autoantibody profiles.

Synchronous Twin Malignancies in a Young Female: A Case Report

Synchronous twin malignancies, defined as the simultaneous occurrence of two distinct primary cancers in the same patient, represent a…

Advancing Frontiers in Myeloproliferative Neoplasms

THE 30th EUROPEAN Hematology Association (EHA) Congress marked a pivotal year in advancing the treatment and understanding…

Lenzilumab and Azacitidine Combination Therapy in Proliferative CMML

Chronic myelomonocytic leukaemia (CMML) is a rare cancer orchestrated by granulocyte-macrophage colony-stimulating factor (GM-CSF)…

MRD in Clinical and Regulatory Decisions

THE EUROPEAN Hematology Association-European Medicines Agency (EHA2025-EMA) Joint Symposium on minimal residual disease (MRD)…

Vitamin K-Dependent Bleeding Linked to Topiramate

Topiramate is a well-known medication used for migraine and epilepsy. Bleeding is a rare and less documented side-effect of this treatment…

Evolving Endpoint Strategies

SINGLE clinical trial endpoints often fall short in capturing the full scope of patient experience, particularly in complex conditions…

Steven Okoli

Hema Now: Episode 22: The State of Sickle Cell

Steven Okoli, Honorary Senior Clinical Lecturer at Imperial College London, shares how AI, advocacy, and stem cell trials are driving the next chapter in sickle cell care.

ICML 2025: Combining Radiation and Bispecific Antibodies in Blood Cancer

A new study presented at the 2025 International Conference on Malignant Lymphoma (ICML) has shown that radiation therapy can be safely integrated with bispecific antibody treatment in patients with relapsed or refractory blood cancers…

Loading posts...

« Previous 1 … 6 7 8 9 10 … 95 Next »